查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654297

全球敗血症藥物市場：市場規模、佔有率、趨勢分析（按藥物類別、給藥途徑、分銷管道和地區）、細分市場預測（2025-2030 年）

Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 153 Pages | 商品交期: 2-10個工作天內

價格

敗血症藥物市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球敗血症藥物市場預計到2030年將達到56.4億美元，2025年至2030年期間的複合年成長率為6.18%。

由於敗血症盛行率不斷上升以及對有效治療方案的需求不斷成長，敗血症藥物產業正在經歷顯著成長。敗血症是一種由感染疾病引起的危及生命的疾病，也是全世界的主要死亡原因，尤其是對於老年人和免疫力等弱勢群體。人們對敗血症的認知不斷提高，以及醫療保健基礎設施的進步，推動了對新型有效治療方法的需求，從而促進了市場成長。

推動市場擴大的主要因素是用於治療的抗生素種類繁多。Aminoglycosides抗生素，例如慶大霉素，由於其對革蘭氏陰性細菌具有頻譜活性，仍然是敗血症治療的主要藥物。此外，頭孢菌素也被廣泛使用，因為它們能有效治療多種感染疾病，特別是由革蘭氏陽性菌引起的感染疾病。萬古黴素等糖肽在敗血症的治療中也發揮重要作用，尤其是對抗藥性感染疾病。卡巴培南類和BETA-內醯胺類抗生素等其他藥物類別的存在進一步擴展了治療前景。

敗血症藥物有多種形式，包括口服、腸外（注射）和其他製劑，使其用途廣泛且可供各種醫療環境中的患者使用。口服藥物對於門診治療很方便，而對於需要即時介入的嚴重病例，腸外製劑是不可或缺的。其他劑型的日益普及也支持了個人化醫療。

在通路方面，醫院藥房仍然是敗血症藥物的一級資訊來源，確保重症監護室備有必要的藥物。零售藥局透過提供可輕鬆取得的藥品來擴大其作用，而網路藥局則透過提供易於取得的敗血症藥物而獲得市場認可，進一步推動了市場成長。隨著全球醫療保健機會和治療意識的不斷提高，敗血症藥物產業將在未來幾年繼續擴張。

敗血症藥物市場報告重點

  • 依藥物類別分類，頭孢菌素類在 2024 年佔據最大的市場佔有率。這項優點是由於頭孢菌素對多種細菌感染具有廣譜功效，包括革蘭氏陽性病原體和革蘭氏陰性病原體。
  • 根據給藥途徑，腸外製劑在 2024 年佔據市場主導地位。腸外製劑，包括靜脈注射和肌肉注射，具有快速輸送和高生物利用度的特點，因此對於膿毒症的即時治療至關重要，尤其是對於重症患者。
  • 根據分銷管道，醫院藥房將在 2024 年繼續佔據主導地位。醫院藥局對於確保及時和適當提供敗血症藥物至關重要，特別是在加護病房(ICU) 和急診室，因為快速獲得救生護理至關重要。
  • 由於先進的醫療基礎設施、疾病盛行率上升以及有利的法規環境等因素，北美將在 2024 年主導敗血症藥物市場。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3. 敗血症藥物市場：促進因素、趨勢與範圍

  • 母市場展望
  • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 敗血症藥物市場：分析工具
    • 波特五力分析
    • PESTEL 分析

第 4 章 敗血症藥物市場：展望、估計與預測（按類型）

  • 敗血症藥物市場：按類型分類的儀表板
  • 敗血症藥物市場：按類型進行趨勢分析（2024 年和 2030 年）
  • 頭孢菌素
  • Aminoglycosides
  • 糖肽
  • 其他藥物類別

第 5 章 敗血症藥物市場：展望、估計與依給藥途徑預測

  • 敗血症藥物市場：按給藥途徑分類的儀表板
  • 敗血症藥物市場：依給藥途徑進行的變化分析（2024 年和 2030 年）
  • 腸外
  • 口服
  • 其他

第 6 章敗血症藥物市場：展望、估計與按分銷管道預測

  • 敗血症藥物市場：按分銷管道分類的儀表板
  • 敗血症藥物市場：按分銷管道分類的趨勢分析（2024 年和 2030 年）
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 7 章敗血症藥物市場：展望、估計與區域預測

  • 敗血症藥物市場佔有率（按地區分類） (2024 年和 2030 年)
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 南非

第8章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Pfizer, Inc.
    • GSK plc.
    • AstraZeneca
    • Eli Lilly and Company
    • Astellas Pharma Inc.
    • Asahi Kasei Corporation
    • InflaRx GmbH
    • La Jolla Pharmaceutical Co.
    • T2 Biosystems Inc.
    • Aridis Pharmaceuticals Inc.
Product Code: GVR-4-68040-506-0

Sepsis Therapeutics Market Growth & Trends:

The global sepsis therapeutics market size is anticipated to reach USD 5.64 billion by 2030, growing at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. The sepsis therapeutics industry is experiencing significant growth due to the increasing prevalence of sepsis and the rising demand for effective treatment options. Sepsis, a life-threatening condition triggered by an infection, is a leading cause of mortality globally, particularly among vulnerable populations such as the elderly and those with compromised immune systems. The growing awareness about sepsis, alongside advancements in healthcare infrastructure, is driving the demand for novel and effective therapies, propelling market growth.

A key factor contributing to the expansion of the market is the wide range of antibiotics used in the treatment. Aminoglycosides, such as gentamicin, continue to be a mainstay in sepsis management due to their broad-spectrum activity against Gram-negative bacteria. Additionally, cephalosporins are widely prescribed because of their effectiveness in treating various infections, especially those caused by Gram-positive bacteria. Glycopeptides, such as vancomycin, are also critical in sepsis therapy, particularly for resistant infections. The presence of other drug classes like carbapenems and beta-lactams further enhances the treatment landscape.

The availability of sepsis therapeutics in various forms, including oral, parenteral (injectable), and other formulations, ensures better accessibility and versatility for patients across different healthcare settings. Oral medications are convenient for outpatient treatment, while parenteral formulations are vital for severe cases requiring immediate intervention. The growing availability of other drug forms also supports personalized care.

In terms of distribution channels, hospital pharmacies continue to be the primary source of sepsis therapeutics, ensuring that critical care units are stocked with necessary treatments. Retail pharmacies are expanding their role in providing accessible medications, while online pharmacies are gaining traction by offering easy access to sepsis drugs, further boosting market growth. As healthcare access and treatment awareness increase globally, the sepsis therapeutics industry is poised for continued expansion in the coming years.

Sepsis Therapeutics Market Report Highlights:

  • The drug class segment of cephalosporins held the largest market share in 2024. This dominance can be attributed to the broad-spectrum efficacy of cephalosporins against a wide range of bacterial infections, including both Gram-positive and Gram-negative pathogens.
  • In the route of administration segment, parenteral formulations dominated the market in 2024. Parenteral drugs, including intravenous and intramuscular injections, offer rapid delivery and higher bioavailability, making them essential for the immediate treatment of sepsis, especially in critical care settings.
  • Based on distribution channel, hospital pharmacies remained the dominant segment in 2024. Hospital pharmacies are critical in ensuring timely and adequate provision of sepsis therapeutics, particularly in intensive care units (ICUs) and emergency departments where quick access to lifesaving treatments is essential.
  • North America dominated the market for sepsis therapeutics in 2024, owing to factors such as advanced healthcare infrastructure, rising disease prevalence, and favorable regulatory environment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Sepsis Therapeutics Market Variables, Trends, & Scope

  • 3.1. Parent Market Outlook
  • 3.2. Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of sepsis cases
      • 3.3.1.2. Advancements in modern therapeutics
      • 3.3.1.3. Rising investment in sepsis research and drug development
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of advanced therapies
      • 3.3.2.2. Lack of awareness and early diagnosis in some regions
  • 3.4. Sepsis Therapeutics Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Sepsis Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Sepsis Therapeutics Market: Type Segment Dashboard
  • 4.2. Sepsis Therapeutics Market: By Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Cephalosporin
    • 4.3.1. Cephalosporin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Aminoglycosides
    • 4.4.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Glycopeptide
    • 4.5.1. Glycopeptide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Drug Class
    • 4.6.1. Other Drug Class Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Sepsis Therapeutics Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Sepsis Therapeutics Market: Route of Administration Segment Dashboard
  • 5.2. Sepsis Therapeutics Market: By Route of Administration Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Parenteral
    • 5.3.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Sepsis Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Sepsis Therapeutics Market: Distribution Channel Segment Dashboard
  • 6.2. Sepsis Therapeutics Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Online Pharmacies
    • 6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Sepsis Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Sepsis Therapeutics Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Sepsis Therapeutics Market Estimates and Forecasts, 2018- 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Sepsis Therapeutics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Pfizer, Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. GSK plc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. AstraZeneca
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Eli Lilly and Company
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Astellas Pharma Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Asahi Kasei Corporation
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. InflaRx GmbH
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. La Jolla Pharmaceutical Co.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. T2 Biosystems Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Aridis Pharmaceuticals Inc.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 5 Global Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 North America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 11 U.S. Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Canada Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Mexico Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Europe Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 24 Germany Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Germany Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 UK Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 27 UK Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 UK Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 30 France Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 France Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Italy Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Italy Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Spain Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Spain Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 Spain Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Denmark Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Denmark Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Sweden Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Sweden Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Norway Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Norway Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 52 China Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 China Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Japan Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Japan Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Japan Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 India Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 58 India Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 India Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 South Korea Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 61 South Korea Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 South Korea Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Australia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 64 Australia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Australia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Thailand Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Thailand Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Latin America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Latin America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Brazil Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Brazil Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 77 Argentina Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 South Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 84 South Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 90 UAE Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 UAE Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Sepsis therapeutics market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Sepsis therapeutics market: Drug class movement analysis
  • Fig. 16 Sepsis therapeutics market: Drug class Outlook and key takeaways
  • Fig. 17 Cephalosporin sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 18 Aminoglycosides sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 19 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 20 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 21 Sepsis therapeutics market: Treatment movement analysis
  • Fig. 22 Sepsis therapeutics market: Treatment outlook and key takeaways
  • Fig. 23 Parenteral market estimates and forecasts, 2018 - 2030
  • Fig. 24 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030
  • Fig. 26 Sepsis therapeutics market: Distribution channel movement analysis
  • Fig. 27 Sepsis therapeutics market: Distribution channel outlook and key takeaways
  • Fig. 28 Hospital pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 29 Retail pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 30 Online pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 Regional Outlook, 2024 & 2030
  • Fig. 33 Global sepsis therapeutics market, Region Movement Analysis
  • Fig. 34 North America sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 40 UK sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 41 France sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 49 China sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 50 India sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 60 UAE sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait sepsis therapeutics market, 2018 - 2030 (USD Million)